Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis

Completed · Phase 4

Conditions studied: Blepharitis

In brief

The purpose of this study is to evaluate the safety and efficacy of AzaSite® ophthalmic solution, 1% on signs and symptoms of blepharitis.

Key facts

Study ID: NCT00629980
Run by: Merck Sharp & Dohme LLC
People needed: 60
Starts: 2008-02-01
Last updated by the study team: 2011-09-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

diagnosis of moderate to severe chronic blepharitis
if female of childbearing potential, are non-pregnant and non-lactating

You may not qualify if…

had ocular surface surgery (LASIK, refractive, etc.) within the past year
unwilling to discontinue the use of contact lenses during the study
have glaucoma
unable or unwilling to withhold the use of lid scrubs during the study
have a serious systemic disease or uncontrolled medical condition that in the judgment of the investigator could confound study assessments or limit compliance
currently using any preserved topical ocular medications (with the exception of unpreserved tear substitutes) at the time of entry into the study or during study participation

Where it is running

Sall Research Medical Center — Artesia, California, United States
North Valley Eye Medical Group — Mission Hills, California, United States
Center for Excellence in Eye Care — Miami, Florida, United States
Kentuckiana Institute for Eye Research — Louisville, Kentucky, United States
Tauber Eye Center — Kansas City, Missouri, United States
Silverstein Eye Centers — Kansas City, Missouri, United States
South Shore Eye Care, LLP — Wantagh, New York, United States
Toyos Clinic — Jackson, Tennessee, United States
Corona Research Consultants, Inc. — El Paso, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.